EUVIMEDEUVIMED entdecken
Leitlinie

Specification of variant interpretation guidelines for inherited retinal dystrophy in Japan

Kaoru Fujinami, Koji M Nishiguchi, Akio Oishi, Masato Akiyama, Yasuhiro Ikeda, Research Group on Rare, Intractable Diseases (Ministry of Health, Labour, Welfare of Japan)

Japanese Journal of Ophthalmology · 2024

DOI: 10.1007/s10384-024-01063-5 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Japanese Journal of Ophthalmology, 2024. Verfasst von Kaoru Fujinami und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Visual Physiology, Division of Vision Research, National Institute of Sensory Organs, NHO Tokyo Medical Center, Tokyo, 152-8902, Japan. Hauptthemen laut MEDLINE: Genetic Testing, Retinal Dystrophies. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development, Ministry of Health, Labour and Welfare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Accurate interpretation of sequence variants in inherited retinal dystrophy (IRD) is vital given the significant genetic heterogeneity observed in this disorder. To achieve consistent and accurate diagnoses, establishment of standardized guidelines for variant interpretation is essential. The American College of Medical Genetics and Genomics/Association for Molecular Pathology (ACMG/AMP) guidelines for variant interpretation serve as the global "cross-disease" standard for classifying variants in Mendelian hereditary disorders. These guidelines propose a systematic approach for categorizing variants into 5 classes based on various types of evidence, such as population data, computational data, functional data, and segregation data. However, for clinical genetic diagnosis and to ensure standardized diagnosis and treatment criteria, additional specifications based on features associated with each disorder are necessary. In this context, we present a comprehensive framework outlining the newly specified ACMG/AMP rules tailored explicitly to IRD in the Japanese population on behalf of the Research Group on Rare and Intractable Diseases (Ministry of Health, Labour and Welfare of Japan). These guidelines consider disease frequencies, allele frequencies, and both the phenotypic and the genotypic characteristics unique to IRD in the Japanese population. Adjustments and modifications have been incorporated to reflect the specific requirements of the population. By incorporating these IRD-specific factors and refining the existing ACMG/AMP guidelines, we aim to enhance the accuracy and consistency of variant interpretation in IRD cases, particularly in the Japanese population. These guidelines serve as a valuable resource for ophthalmologists and clinical geneticists involved in the diagnosis and treatment of IRD, providing them with a standardized framework to assess and classify genetic variants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic TestingRetinal DystrophiesHumansGenetic VariationGenotypeJapanMutationPhenotype

Stichwörter der Autor:innen

ACMG/AMP guidelinesGenetic diagnosisInherited retinal dystrophyJapaneseVariant interpretation

Autor:innen und Institutionen

  • Laboratory of Visual Physiology, Division of Vision Research, National Institute of Sensory Organs, NHO Tokyo Medical Center, Tokyo, 152-8902, Japan.
  • Department of Ophthalmology, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-ku, Nagoya, 466-8550, Japan. kmn@med.nagoya-u.ac.jp.
  • Department of Ophthalmology and Visual Sciences, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, 852-8501, Japan.
  • Department of Ocular Pathology and Imaging Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, 812-8582, Japan.
  • Department of Ophthalmology, Faculty of Medicine, University of Miyazaki, Miyazaki, 889-1692, Japan.

Förderung

  • Japan Agency for Medical Research and Development
  • Ministry of Health, Labour and Welfare

Zitieren

APA

Fujinami, K., Nishiguchi, K. M., Oishi, A., Akiyama, M., Ikeda, Y., & Research Group on Rare, Intractable Diseases (Ministry of Health, Labour, Welfare of Japan) (2024). Specification of variant interpretation guidelines for inherited retinal dystrophy in Japan. Japanese Journal of Ophthalmology. https://doi.org/10.1007/s10384-024-01063-5

Vancouver

Fujinami K, Nishiguchi KM, Oishi A, Akiyama M, Ikeda Y, Research Group on Rare, Intractable Diseases (Ministry of Health, Labour, Welfare of Japan). Specification of variant interpretation guidelines for inherited retinal dystrophy in Japan. Japanese Journal of Ophthalmology. 2024. doi:10.1007/s10384-024-01063-5

BibTeX
@article{Fujinami2024,
  author = {Fujinami, Kaoru and Nishiguchi, Koji M and Oishi, Akio and Akiyama, Masato and Ikeda, Yasuhiro and Research Group on Rare, Intractable Diseases (Ministry of Health, Labour, Welfare of Japan), Research Group on Rare, Intractable Diseases (Ministry of Health, Labour, Welfare of Japan)},
  title = {Specification of variant interpretation guidelines for inherited retinal dystrophy in Japan},
  journal = {Japanese Journal of Ophthalmology},
  year = {2024},
  doi = {10.1007/s10384-024-01063-5}
}
Kostenlos starten →